MoneyWorks4Me

Omkar Pharmachem - Quaterly Results

14 Feb 2025 Evaluate
Revenue showed a marginal decline at Rs. 1.35 millions. For the quarter ended December 2024, as compared to corresponding quarter of last year.A good growth in profit of 25.37% reported to Rs. 0.84  millions over Rs. 0.67 millions of corresponding previous quarter.OP of the company witnessed a marginal growth to 0.86 millions from 0.68 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1.35 1.35 0.00 4.05 4.05 0.00 5.40 5.40 0.00
Other Income 0.02 0.00 0.00 0.02 0.00 0.00 0.03 0.03 0.00
PBIDT 0.86 0.68 26.47 2.25 2.09 7.66 2.87 3.13 -8.31
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.29 0.46 -36.96
PBDT 0.86 0.68 26.47 2.25 2.09 7.66 2.58 2.67 -3.37
Depreciation 0.02 0.01 100.00 0.04 0.03 33.33 0.05 0.03 66.67
PBT 0.84 0.67 25.37 2.21 2.06 7.28 2.53 2.64 -4.17
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.64 0.67 -4.48
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.84 0.67 25.37 2.21 2.06 7.28 1.89 1.97 -4.06
Equity 100.84 100.84 0.00 100.84 100.84 0.00 100.84 100.84 0.00
PBIDTM(%) 63.70 50.37 26.47 55.56 51.60 7.66 53.15 57.96 -8.31
Peers
Company Name CMP
Sagility 43.12
Prime Focus 301.65
Knowledge RealtyTrt. 112.24
Indegene 594.00
Syngene Internatl. 360.95
View more..